|
ImmuPharma PLC - specialist drug discovery and development company - Raises £950,000 under broker option, taking total proceeds from placing and broker option to £1.04 million. ‘Further to the announcement of August 3, 2022, the directors confirm that the fundraising, together with existing funding and funding arrangements, will provide the company with sufficient working capital for at least the next 12 months,’ it says.
Current stock price: 5.17 pence
12-month change: down 45%
Copyright 2022 Alliance News Limited. All Rights Reserved.
|
